(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on GH Research (GHRS – Research Report), with a price ...
Rodman & Renshaw maintained a Buy rating on Compass Pathways (NASDAQ:CMPS) but significantly reduced the 12-month price ...
WOOD Grand Rapids on MSN21h
Nose spray to treat depression? FDA approves first-of-its-kind medicineThe U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
In the first part of their two-part paper, Consulting Engineer Professor Robert Jackson and General Practitioner Dr Frederick ...
Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...
Harm reduction isn't just a strategy; it's an act of compassion that rewrites the script of addiction treatment, offering a ...
The best chip and break-resistant dinnerware is a worthy and long-term investment because it is very durable and beautiful. However, some of them are more durable than others while many of them are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback